A step by step guide to Prostate Cancer procedure steps, including PSA screening, mpMRI, and biopsy methods for accurate diagnosis and staging.
Send us all your questions or requests, and our expert team will assist you.
Accurate diagnosis and staging are the cornerstones of effective prostate cancer care, especially for international patients seeking world‑class treatment at Liv Hospital. By precisely identifying the presence of cancer and determining how far it has spread, clinicians can tailor therapy to each individual’s disease biology and personal goals. In Europe, prostate cancer accounts for roughly one in five new cancer diagnoses in men, and early, accurate staging dramatically improves long‑term outcomes. This page walks you through every step of the diagnostic pathway—from blood tests and biopsies to advanced imaging and risk‑group classification—so you understand what to expect when you choose Liv Hospital for your care.
Whether you have been referred after an elevated PSA, experienced urinary symptoms, or are pursuing a routine health check‑up, our multidisciplinary team uses the latest evidence‑based protocols to ensure that every piece of information is captured accurately. The following sections detail the laboratory, imaging, and pathological tools we employ, explain how they fit into internationally recognized staging systems, and illustrate how these results shape a personalized treatment plan.
The first step in diagnosis and staging begins with a thorough laboratory work‑up. Blood tests not only confirm the suspicion of prostate cancer but also provide baseline data essential for treatment planning and monitoring.
Beyond PSA, we assess hormonal status and organ function to prepare for potential systemic therapies. A typical panel includes testosterone, liver function tests, and renal function markers. These results are recorded in a structured table to aid multidisciplinary discussion.
These laboratory results, combined with clinical findings, guide the decision to proceed with imaging and biopsy, forming the foundation of accurate diagnosis and staging.
Modern imaging is essential for mapping the extent of prostate cancer beyond the prostate gland. Liv Hospital offers a full suite of high‑resolution techniques, each selected based on disease risk and patient factors.
Bone scans detect skeletal metastases, a common site for advanced prostate cancer. NaF PET/CT offers higher sensitivity and is increasingly used for early detection of bone involvement.
Contrast‑enhanced CT of the abdomen and pelvis evaluates lymph node involvement and potential visceral metastases. Pelvic MRI complements CT by providing superior soft‑tissue contrast for local staging.
Choosing the appropriate imaging sequence is a collaborative decision made by our urologists, radiologists, and oncologists, ensuring that each patient receives the most informative assessment for accurate diagnosis and staging.
Definitive diagnosis requires tissue sampling. At Liv Hospital, we perform both systematic and MRI‑targeted biopsies, maximizing detection of clinically significant cancer while minimizing unnecessary cores.
Pathologists assign a Gleason score based on the architectural pattern of cancer cells. The newer Grade Group system (1–5) simplifies risk communication:
These pathological findings, combined with imaging and laboratory data, complete the diagnosis and staging process, allowing our multidisciplinary tumor board to assign a precise disease stage.
Prostate cancer staging follows the American Joint Committee on Cancer (AJCC) TNM framework, complemented by risk stratification models that integrate PSA, Gleason Grade Group, and clinical stage.
The D’Amico system categorizes patients into low, intermediate, or high risk based on three parameters:
By mapping each patient’s data onto both the TNM stage and risk group, our clinicians can predict outcomes, discuss therapeutic options, and set realistic expectations. This dual‑system approach is integral to the comprehensive diagnosis and staging workflow at Liv Hospital.
Once the full diagnostic picture is assembled, a personalized treatment plan is crafted. Staging determines whether a patient is a candidate for curative intent therapies or requires systemic management.
When staging reveals nodal involvement (N1) or distant metastasis (M1), we incorporate systemic treatments such as androgen deprivation therapy (ADT), novel hormonal agents (abiraterone, enzalutamide), chemotherapy, or targeted radionuclide therapy (Radium‑223). Liv Hospital’s oncology team coordinates these modalities with supportive care services, ensuring continuity for international patients.
Every case is presented at a weekly tumor board that includes urologists, medical oncologists, radiation oncologists, radiologists, pathologists, and nursing specialists. This collaborative review guarantees that the chosen treatment aligns with the patient’s stage, comorbidities, personal preferences, and travel logistics.
Through this rigorous, stage‑driven pathway, Liv Hospital transforms the complex data gathered during diagnosis and staging into a clear, actionable plan that maximizes therapeutic benefit while minimizing unnecessary interventions.
Liv Hospital is a JCI‑accredited, internationally focused medical center in Istanbul, offering a seamless experience for patients traveling from abroad. Our dedicated International Patient Services team handles appointments, airport transfers, interpreter support, and comfortable accommodation options, allowing you to focus solely on your health. Backed by state‑of‑the‑art technology, a multilingual staff, and a proven track record in oncology, we deliver high‑quality, patient‑centered care that meets global standards.
Ready to take the next step in your prostate cancer journey? Contact Liv Hospital today to schedule a comprehensive diagnostic evaluation and receive a personalized staging report. Our experts are standing by to guide you through every phase of care, from initial testing to tailored treatment.
Send us all your questions or requests, and our expert team will assist you.
Liv Hospital begins the diagnostic pathway with a comprehensive blood panel. PSA is the primary marker, and its trend over time helps differentiate aggressive from indolent disease. The free‑to‑total PSA ratio improves specificity when total PSA is borderline (4–10 ng/mL). Alkaline phosphatase and calcium flag possible bone metastases, while LDH can reflect tumor burden in advanced cases. Hormonal status (testosterone) and organ function tests are also measured to prepare for systemic therapies. All results are compiled in a structured table for multidisciplinary discussion.
Multiparametric MRI combines anatomical and functional sequences to map the prostate in detail. It pinpoints lesions that may be missed by systematic biopsy, allowing MRI‑fusion targeted sampling. Additionally, mpMRI evaluates capsular involvement, seminal vesicle invasion, and neurovascular bundle proximity, which are critical for local staging and surgical planning. The technique requires experienced radiologists, and while it may miss microscopic disease, it remains the gold standard for local assessment.
Diagnostic procedures like the Fusion Biopsy are not painful because local anesthesia is used. Mild post-procedure soreness is expected but easily managed.
Diagnostic accuracy is very high, especially with mpMRI-Fusion Biopsy. Treatment accuracy is high, with robotic surgery ensuring precise removal of the prostate.
You need advanced procedures (mpMRI, Fusion Biopsy) if your PSA level is high or rising, or if a physical exam reveals a suspicious lump.
BlogCancerFeb 19, 2026We often hear about cancer being diagnosed at various stages. Stage zero is the earliest, non-invasive stag...
BlogCancerFeb 19, 2026Prostate cancer is a big worry for men. The American Cancer Society says there will be 313,780 new cases an...
BlogCancerFeb 19, 2026Prostate cancer is a big health worry for men all over the world. It’s the second most common cancer ...
BlogCancerFeb 19, 2026Prostate cancer is a big worry for men all over the world. But, the good news is that it can often be cured...
BlogCancerFeb 19, 2026Prostate cancer is a significant concern for men, particularly in the U.S., where it constitutes a major po...
BlogCancerFeb 19, 2026Men worried about prostate health or dealing with Benign Prostatic Hyperplasia (BPH) should know some drink...
